Nurse Practitioner, Family · Coppell, TX
NPI
1578107744
Since 2019
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
917 Deforest Rd
Coppell, TX, 75019
Phone (469) 569-0581
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$854K
5,071 prescriptions
Company payments, 2024
$312
From 10 companies
Medicare prescription drug claims, 2024
In 2024, the drug Ambreen Alwani prescribed most often to Medicare patients was Atorvastatin Calcium, with 278 prescriptions and refills. In total Ambreen Alwani wrote 5,071 Medicare prescriptions that cost $854K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-10-31.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 278 | 880 | 103 | $2,260 |
| Rosuvastatin Calcium Generic | 238 | 753 | 87 | $2,177 |
| Amlodipine Besylate Generic | 237 | 740 | 89 | $1,638 |
| Losartan Potassium Generic | 227 | 710 | 82 | $1,808 |
| Lisinopril Generic | 176 | 563 | 62 | $1,481 |
| Metformin Hcl Generic | 152 | 490 | 61 | $1,219 |
| Pantoprazole Sodium Generic | 124 | 382 | 53 | $1,200 |
| Levothyroxine Sodium Generic | 124 | 387 | 45 | $1,168 |
| Gabapentin Generic | 111 | 340 | 52 | $2,882 |
| Montelukast Sodium Generic | 92 | 285 | 42 | $805 |
| Furosemide Generic | 91 | 266 | 36 | $442 |
| Tamsulosin Hcl Generic | 87 | 272 | 33 | $626 |
| Pravastatin Sodium Generic | 83 | 269 | 35 | $854 |
| Carvedilol Generic | 83 | 266 | 32 | $634 |
| Atenolol Generic | 82 | 250 | 30 | $644 |
Brand drugs: 698 claims; generic drugs: 4,217 claims; opioid claims: 70.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Ambreen Alwani $312 ($312 in general payments such as food, travel and fees) from 10 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $65.96.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $65.96 |
| Lilly USA, LLC LLY | 3 | $49.92 |
| Novo Nordisk Inc NVO | 2 | $44.85 |
| GlaxoSmithKline, LLC. GSK | 2 | $33.58 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $31.55 |
| Pfizer Inc. PFE | 1 | $22.62 |
| Boston Scientific Corporation BSX | 1 | $19.43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $15.91 |
| Amgen Inc. AMGN | 1 | $15.2 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $13.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.